By [ad_1]
Gland Pharma Ltd.’s second-quarter profit declined, missing forecasts.Net profit of the Hyderabad-based generic injectable manufacturer fell 20% year-on-year to Rs 241 crore in the three months through September, according to its exchange filing. That compares with the Rs 259-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, the profit rose 5%.Gland Pharma Q2 Highlights (YoY)Revenue fell 3% to Rs 1,044 crore, ag…
[ad_2]
Source link
What is your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
